| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
|
Circulation
|
1993
|
3.29
|
|
2
|
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.
|
Cancer
|
1991
|
2.98
|
|
3
|
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.
|
N Engl J Med
|
1986
|
2.70
|
|
4
|
Hepatic resection for metastatic neuroendocrine carcinomas.
|
Am J Surg
|
1995
|
1.82
|
|
5
|
Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
|
Cancer Res
|
1990
|
1.72
|
|
6
|
Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil.
|
Int J Radiat Oncol Biol Phys
|
1993
|
1.71
|
|
7
|
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer.
|
N Engl J Med
|
1981
|
1.70
|
|
8
|
Primary signet ring cell adenocarcinoma of the bladder.
|
J Urol
|
1989
|
1.55
|
|
9
|
Cytoreductive hepatic surgery for neuroendocrine tumors.
|
Surgery
|
1990
|
1.47
|
|
10
|
A clinical trial of amygdalin (Laetrile) in the treatment of human cancer.
|
N Engl J Med
|
1982
|
1.47
|
|
11
|
Diagnosis of corticotropin-producing bronchial carcinoid tumors causing Cushing's syndrome.
|
Mayo Clin Proc
|
1990
|
1.46
|
|
12
|
Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea.
|
N Engl J Med
|
1993
|
1.45
|
|
13
|
The glucagonoma syndrome. Clinical and pathologic features in 21 patients.
|
Medicine (Baltimore)
|
1996
|
1.33
|
|
14
|
Outcome of cardiac surgery for carcinoid heart disease.
|
J Am Coll Cardiol
|
1995
|
1.25
|
|
15
|
The management of patients with advanced carcinoid tumors and islet cell carcinomas.
|
Ann Intern Med
|
1994
|
1.22
|
|
16
|
A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea.
|
Gastroenterology
|
1994
|
1.14
|
|
17
|
External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer.
|
Cancer
|
1988
|
1.13
|
|
18
|
Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995).
|
Ann Intern Med
|
1987
|
1.05
|
|
19
|
Intraoperative and external beam irradiation +/- 5-FU for locally advanced pancreatic cancer.
|
Int J Radiat Oncol Biol Phys
|
1987
|
1.05
|
|
20
|
Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole.
|
Ann Neurol
|
1992
|
1.02
|
|
21
|
A phase I clinical trial of recombinant human tumor necrosis factor.
|
Cancer
|
1988
|
1.02
|
|
22
|
Chemotherapy of endocrine malignancies: a review.
|
Semin Oncol
|
1987
|
1.00
|
|
23
|
Rapid reversal of carcinoid crisis with a somatostatin analogue.
|
N Engl J Med
|
1985
|
0.99
|
|
24
|
Transtracheal selective bronchial brushing for pulmonary infiltrates in patients with cancer.
|
Chest
|
1976
|
0.97
|
|
25
|
Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon.
|
J Clin Oncol
|
1989
|
0.95
|
|
26
|
A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors.
|
Cancer
|
2001
|
0.94
|
|
27
|
A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors.
|
Endocr Relat Cancer
|
2013
|
0.94
|
|
28
|
Rothmund-Thomson syndrome in siblings: evidence for acquired in vivo mosaicism.
|
Clin Genet
|
1996
|
0.92
|
|
29
|
Familial testicular cancer: report of six cases and review of the literature.
|
Mayo Clin Proc
|
1990
|
0.91
|
|
30
|
Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia.
|
World J Surg
|
1995
|
0.90
|
|
31
|
Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy.
|
Am J Med
|
1986
|
0.89
|
|
32
|
Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease.
|
Cancer Treat Rep
|
1979
|
0.89
|
|
33
|
Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.
|
Cancer Treat Rep
|
1977
|
0.87
|
|
34
|
A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
|
Cancer
|
1991
|
0.87
|
|
35
|
Intraoperative and external beam irradiation with or without resection: Mayo pilot experience.
|
Mayo Clin Proc
|
1984
|
0.86
|
|
36
|
Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report.
|
Cancer Treat Rep
|
1977
|
0.86
|
|
37
|
Disposition of tricyclic nucleoside-5'-monophosphate in blood and plasma of patients during phase I and II clinical trials.
|
Cancer Treat Rep
|
1986
|
0.86
|
|
38
|
Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors.
|
Mayo Clin Proc
|
1996
|
0.86
|
|
39
|
Phase I-II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinoma.
|
Invest New Drugs
|
1991
|
0.86
|
|
40
|
Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging, and treatment of tumors.
|
Gastroenterology
|
1993
|
0.86
|
|
41
|
Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors.
|
Cancer
|
1997
|
0.85
|
|
42
|
Phase I trial of parenteral 6-thioguanine given on 5 consecutive days.
|
Cancer Res
|
1986
|
0.85
|
|
43
|
A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer.
|
Cancer
|
1992
|
0.85
|
|
44
|
Carcinoid disease of the heart. Surgical management of ten patients.
|
J Thorac Cardiovasc Surg
|
1992
|
0.84
|
|
45
|
A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate.
|
Cancer
|
1990
|
0.83
|
|
46
|
Expression of somatostatin receptors in childhood neuroblastoma.
|
Am J Clin Pathol
|
1994
|
0.83
|
|
47
|
Evaluation of external-beam radiation therapy plus 5-fluorouracil (5-FU) versus external-beam radiation therapy plus hycanthone (HYC) in confined, unresectable pancreatic cancer.
|
Int J Radiat Oncol Biol Phys
|
1994
|
0.83
|
|
48
|
Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.
|
Cancer Treat Rep
|
1980
|
0.83
|
|
49
|
Progressive carcinoid heart disease after resection of primary ovarian carcinoid.
|
Cancer
|
1994
|
0.82
|
|
50
|
MRI of pancreatic islet cell carcinoma.
|
J Comput Assist Tomogr
|
1993
|
0.82
|
|
51
|
Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.
|
Cancer Treat Rep
|
1987
|
0.81
|
|
52
|
Chemotherapy of metastatic carcinoid and islet cell tumors. A review.
|
Am J Med
|
1987
|
0.80
|
|
53
|
Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.
|
Cancer Treat Rep
|
1978
|
0.80
|
|
54
|
Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
|
Cancer
|
1977
|
0.80
|
|
55
|
Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma.
|
J Clin Endocrinol Metab
|
1995
|
0.80
|
|
56
|
An evaluation of low-dose cisplatin as part of combined modality therapy of limited small cell lung cancer.
|
Cancer Clin Trials
|
1981
|
0.80
|
|
57
|
A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors.
|
Ann Oncol
|
2012
|
0.80
|
|
58
|
High-resolution ultrasonographic and pathologic abnormalities of germ cell tumors in patients with clinically normal testes.
|
Mayo Clin Proc
|
1983
|
0.80
|
|
59
|
Carcinoid syndrome secondary to a primary tumour in a Meckel's diverticulum.
|
Aust N Z J Surg
|
1993
|
0.80
|
|
60
|
VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung.
|
Cancer Treat Rep
|
1978
|
0.80
|
|
61
|
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.
|
Cancer Treat Rep
|
1981
|
0.79
|
|
62
|
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancer.
|
Cancer Treat Rep
|
1980
|
0.79
|
|
63
|
Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues.
|
Semin Nucl Med
|
1995
|
0.79
|
|
64
|
Increased parathyroid hormone-related peptide in patients with hypercalcemia associated with islet cell carcinoma.
|
Mayo Clin Proc
|
1997
|
0.78
|
|
65
|
Phase I study of difluoromethylornithine in combination with recombinant alpha 2a-interferon.
|
Cancer Res
|
1988
|
0.77
|
|
66
|
A pilot study to determine clinical tolerability of intensive combined modality therapy for locally unresectable gastric cancer.
|
Int J Radiat Oncol Biol Phys
|
1985
|
0.77
|
|
67
|
Can molgramostim enhance the antitumor effects of cytotoxic drugs in patients with advanced sarcomas?
|
Ann Oncol
|
1997
|
0.77
|
|
68
|
Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue.
|
Anesthesiology
|
1987
|
0.77
|
|
69
|
Rebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma.
|
Am J Med
|
1987
|
0.77
|
|
70
|
Regression of metastatic carcinoid tumor after valvular surgery for carcinoid heart disease.
|
Cancer
|
1997
|
0.77
|
|
71
|
A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy. An Eastern Cooperative Oncology Group pilot study.
|
Invest New Drugs
|
1990
|
0.77
|
|
72
|
A comparison of intra-arterial and cuff blood pressure measurements in very obese subjects.
|
Cardiovasc Res Cent Bull
|
1969
|
0.77
|
|
73
|
Cytotoxic drugs plus subcutaneous granulocyte-macrophage colony-stimulating factor: can molgramostim enhance antisarcoma therapy?
|
J Natl Cancer Inst
|
1994
|
0.77
|
|
74
|
Phase II evaluation of AMSA in patients with metastatic lung cancer.
|
Cancer Treat Rep
|
1980
|
0.76
|
|
75
|
Testicular neoplasms: 29 tumors studied by high-resolution US.
|
Radiology
|
1985
|
0.76
|
|
76
|
Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer.
|
Cancer Treat Rep
|
1981
|
0.76
|
|
77
|
Phase II trial of iv 6-thioguanine in advanced colorectal carcinoma.
|
Cancer Treat Rep
|
1981
|
0.76
|
|
78
|
Randomized trial of thoracic irradiation plus combination chemotherapy for unresectable adenocarcinoma and large cell carcinoma of the lung.
|
Int J Radiat Oncol Biol Phys
|
1979
|
0.76
|
|
79
|
Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma.
|
Invest New Drugs
|
1988
|
0.75
|
|
80
|
Phase II study of maytansine in advanced breast cancer.
|
Cancer Treat Rep
|
1981
|
0.75
|
|
81
|
Dosimetry and biodistribution of an iodine-123-labeled somatostatin analog in patients with neuroendocrine tumors.
|
J Nucl Med
|
1992
|
0.75
|
|
82
|
Failure of bleomycin to improve the therapeutic effects of a combination of cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced sarcomas.
|
Med Pediatr Oncol
|
1984
|
0.75
|
|
83
|
Familial polyposis. A case report.
|
S Afr J Surg
|
1984
|
0.75
|
|
84
|
Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant disease.
|
Cancer
|
1989
|
0.75
|
|
85
|
Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancer.
|
Cancer Treat Rep
|
1982
|
0.75
|
|
86
|
Phase II study of bisantrene administered by continuous 72-hour infusion for advanced pancreatic adenocarcinoma.
|
Med Pediatr Oncol
|
1988
|
0.75
|
|
87
|
Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
|
Cancer Treat Rep
|
1978
|
0.75
|
|
88
|
Indications for and results of intraoperative irradiation for locally advanced colorectal cancer.
|
Front Radiat Ther Oncol
|
1991
|
0.75
|
|
89
|
Phase II trial of diaziquone in advanced upper aerodigestive cancer.
|
Cancer Treat Rep
|
1985
|
0.75
|
|
90
|
Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinoma.
|
Am J Clin Oncol
|
1983
|
0.75
|
|
91
|
Factor IX deficiency and bleeding in a patient with Sheehan's syndrome.
|
Blood
|
1972
|
0.75
|
|
92
|
Phase II evaluation of dianhydrogalactitol in advanced head and neck carcinomas.
|
Cancer Treat Rep
|
1980
|
0.75
|
|
93
|
Reduced uncertainty as a diagnostic benefit: an initial assessment of somatostatic receptor scintigraphy's value in detecting distant metastases of carcinoid liver tumours.
|
Health Econ
|
1998
|
0.75
|
|
94
|
Phase II evaluation of chlorozotocin in advanced bronchogenic carcinoma.
|
Cancer Treat Rep
|
1980
|
0.75
|
|
95
|
Lymphocele after retroperitoneal node dissection for testis tumor.
|
Cancer
|
1986
|
0.75
|
|
96
|
Evaluation of mitolactol in women with advanced breast cancer and prior chemotherapy exposure.
|
Cancer Treat Rep
|
1983
|
0.75
|
|
97
|
Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
|
Oncology
|
1981
|
0.75
|
|
98
|
Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.
|
Cancer Treat Rep
|
1981
|
0.75
|
|
99
|
Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposure.
|
Am J Clin Oncol
|
1985
|
0.75
|
|
100
|
Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
|
Cancer Treat Rep
|
1981
|
0.75
|
|
101
|
Phase II study of maytansine and chlorozotocin in patients with disseminated malignant melanoma.
|
Cancer Treat Rep
|
1981
|
0.75
|
|
102
|
Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer.
|
Cancer Treat Rep
|
1980
|
0.75
|
|
103
|
Residual, recurrent, or unresectable gastrointestinal cancer. Role of radiation in single or combined modality treatment.
|
Cancer
|
1985
|
0.75
|
|
104
|
Comparison of the pharmacokinetics of octreotide injected at two subcutaneous sites.
|
J Natl Cancer Inst
|
1989
|
0.75
|
|
105
|
Phase II evaluation of PALA in patients with metastatic lung cancer.
|
Cancer Treat Rep
|
1981
|
0.75
|
|
106
|
Molecular genetics of neuroendocrine tumors.
|
Curr Opin Oncol
|
1993
|
0.75
|
|
107
|
Evaluation of a fixed alternating treatment in patients with advanced breast cancer.
|
Cancer Clin Trials
|
1978
|
0.75
|
|
108
|
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung.
|
Tumori
|
1979
|
0.75
|
|
109
|
New molecular aspects for the diagnosis and treatment of neuroendocrine gastroenteropancreatic tumors.
|
Ann N Y Acad Sci
|
1994
|
0.75
|
|
110
|
Phase II studies of PCNU and bisantrene in advanced renal cell carcinoma.
|
Cancer Treat Rep
|
1987
|
0.75
|
|
111
|
Phase II evaluation of triazinate in patients with metastatic lung cancer.
|
Cancer Treat Rep
|
1981
|
0.75
|
|
112
|
Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinoma.
|
Recent Results Cancer Res
|
1978
|
0.75
|
|
113
|
Clinical trial of sequential N-phosphonacetyl-L-aspartate, thymidine, and 5-fluorouracil in advanced colorectal carcinoma.
|
J Clin Oncol
|
1984
|
0.75
|
|
114
|
Carcinoid syndrome.
|
J Clin Oncol
|
1998
|
0.75
|
|
115
|
Clinical trial of PALA and L-Alanosine in advanced colorectal carcinoma.
|
Cancer Treat Rep
|
1983
|
0.75
|
|
116
|
Local control and survival in locally advanced gastrointestinal cancer.
|
Int J Radiat Oncol Biol Phys
|
1986
|
0.75
|
|
117
|
Evaluation of vinblastine administered by 5-day continuous infusion in women with advanced breast cancer.
|
Cancer Treat Rep
|
1984
|
0.75
|
|
118
|
Clinical trial of cisplatin and intensive course 5-fluorouracil for the treatment of advanced colorectal cancer.
|
Am J Clin Oncol
|
1986
|
0.75
|
|
119
|
Effect of the somatostatin analogue octreotide acetate on hemostasis in humans.
|
Mayo Clin Proc
|
1991
|
0.75
|
|
120
|
Nuclear medicine imaging of breast cancer.
|
Nucl Med Commun
|
1996
|
0.75
|